Medstream Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-12-2024
- Paid Up Capital ₹ 0.50 M
as on 27-12-2024
- Company Age 34 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.70 M
as on 27-12-2024
- Revenue -1.32%
(FY 2022)
- Profit 171.29%
(FY 2022)
- Ebitda -264.01%
(FY 2022)
- Net Worth 2.15%
(FY 2022)
- Total Assets -23.07%
(FY 2022)
About Medstream Pharmaceuticals (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.70 M.
Vasant Joshi and Vinay Joshi serve as directors at the Company.
- CIN/LLPIN
U30007MH1990PTC058458
- Company No.
058458
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medstream Pharmaceuticals (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasant Joshi  | Director | 22-Nov-1990 | Current |
Vinay Joshi  | Director | 10-May-2001 | Current |
Financial Performance of Medstream Pharmaceuticals (India).
Medstream Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.32% decrease. The company also saw a substantial improvement in profitability, with a 171.29% increase in profit. The company's net worth moved up by a moderate rise of 2.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medstream Pharmaceuticals (India)?
In 2021, Medstream Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quantum Analytical Data Systems Private LimitedActive 16 years 6 monthsVasant Joshi and Vinay Joshi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 04 Feb 2009 | ₹2.70 M | Open |
How Many Employees Work at Medstream Pharmaceuticals (India)?
Unlock and access historical data on people associated with Medstream Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medstream Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medstream Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
